Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
SK Chemicals Co., Ltd. clinical trials
Part of SK Discovery Co., Ltd., which holds 40.79% as of 2025-12-31. Source
The registry lists 69 studies whose lead sponsor is SK Chemicals Co., Ltd. or one of 2 companies grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 15, 2026.
Keep track of what changes. Save the SK Chemicals Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to SK Chemicals Co., Ltd..
- SK Chemicals Co., Ltd.53 studiesSame company
Something wrong?
- SK Bioscience Co., Ltd.12 studies →Subsidiary
Something wrong?
- SK Plasma Co., Ltd.4 studies →Divested
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 69. Browse all 69 →
- SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07415252Phase 3
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a PatientsNot yet recruitingNCT06738901Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
- A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsCompletedNCT06680128Phase 1/2
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.Active, not recruitingNCT07280858Phase 1/2
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic StrokeCompletedNCT05445895Phase 4
- A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.CompletedNCT05906199Phase 4
- Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and OlderCompletedNCT05501522Phase 3
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver TransplantationTerminatedNCT05666453Phase 2
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
- Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)CompletedNCT05007951Phase 3
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.WithdrawnNCT05710289
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical TrialCompletedNCT05930080Phase 3
- A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PDCompletedNCT04821687Phase 4
- Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)CompletedNCT04760743Phase 1
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)CompletedNCT04742738Phase 1/2
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Clinical Trial for GNX80 in Intermittent ClaudicationStatus unknownNCT05400395Phase 4
- A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersCompletedNCT05453786Phase 1
- A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersCompletedNCT05236998Phase 1
- A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)CompletedNCT05566990Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
- Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 MonthsCompletedNCT03704740Phase 3
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)Status unknownNCT04750343Phase 1/2
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Immunogenicity and Safety Study of NBP615 in Healthy FemaleCompletedNCT04453241Phase 1/2
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)CompletedNCT03164915Phase 3
Sponsor listed in the registry: SK Plasma Co., Ltd. · SK Plasma Co., Ltd. — formerly part of SK Chemicals Co., Ltd.
- The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male SubjectsCompletedNCT04401137Phase 1
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly SubjectsCompletedNCT02467842Phase 3
- Immunogenicity and Safety Study of NBP606 in Healthy InfantsCompletedNCT02201030Phase 3
- Immunogenicity and Safety Study of NBP606 in Healthy ToddlersCompletedNCT02927444Phase 3
- Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive DiseaseCompletedNCT03318276Phase 3
- Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114943Phase 3
Sponsor listed in the registry: SK Bioscience Co., Ltd.
- Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy AdultsCompletedNCT03893669Phase 1
- Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult VolunteersCompletedNCT03826719Phase 1/2
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 MonthsCompletedNCT03020628Phase 3
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670CompletedNCT02202408Phase 1
- Safety Study of NBP608 in Healthy Adult VolunteersCompletedNCT03121638Phase 1
- Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03120364Phase 3
- Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03116594Phase 2/3
- The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114982Phase 2
- Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OABCompletedNCT02485067Phase 3
- Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma PatientsTerminatedNCT01907763Phase 3
- Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate VaccineCompletedNCT02079207Phase 3
- Safety/Tolerability and Pharmacokinetic Study of SID142CompletedNCT02625714Phase 1
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and AdolescentsCompletedNCT02621164Phase 3
- Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and AdolescentsCompletedNCT02621177Phase 3
- Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgCompletedNCT02485041Phase 1
- Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mgCompletedNCT02485028Phase 1
- Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With ConstipationCompletedNCT02082457Phase 2
- A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsCompletedNCT01513850Phase 3
- Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel SyndromeCompletedNCT02079675Phase 2
- Assessment of Protective Effect of JOINS on Cartilage in Knee OsteoarthritisCompletedNCT01293955Phase 4
- Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly SubjectsCompletedNCT02344134Phase 3
- Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and AmlodipineCompletedNCT00626743Phase 1